COMT inhibition with entacapone for patients with Parkinson's disease and motor complications: the novelty of continuous infusion. [PDF]
Jenner P, Nyholm D.
europepmc +1 more source
Systematic Analysis of SH-SY5Y Differentiation Protocols and Neuronal Subtype Abundance. [PDF]
Prisacar M +8 more
europepmc +1 more source
Biomarker potential of hsa-miR-145-5p in peripheral whole blood of manic bipolar I patients. [PDF]
Tekin SS +5 more
europepmc +1 more source
Lysine-Targeting Inhibitors of Amyloidogenic Protein Aggregation: A Promise for Neurodegenerative Proteinopathies. [PDF]
Murakami K +4 more
europepmc +1 more source
Implementation of 7-1-7 for improving timeliness in outbreak detection and response in Thailand: A mixed-methods study on challenges in application and achievement of targets in 2024-25. [PDF]
Watakulsin P +12 more
europepmc +1 more source
Novel advanced patient-derived <i>in vitro</i> models of pediatric movement disorders to develop personalized therapeutic strategies. [PDF]
Yeadon S +3 more
europepmc +1 more source
Increased CSF DOPA Decarboxylase Correlates with Lower DaT-SPECT Binding: Analyses in Biopark and PPMI Cohorts. [PDF]
Khosousi S +8 more
europepmc +1 more source
Tailored Kidney Stone Prevention Improves Metabolic Risk Factors and Reduces Renal Colic Rate. [PDF]
Van de Perre E +14 more
europepmc +1 more source
Screening and validation of 3'-Methoxydaidzein as a therapeutic agent in ulcerative colitis based on disulfidptosis-associated molecular clusters. [PDF]
Yuan J, Gao C, Xin W, Meng F, Zhang H.
europepmc +1 more source
Incorporating immune cell surrogates into a full-thickness tissue equivalent of human skin to characterize dendritic cell activation. [PDF]
Hölken JM +10 more
europepmc +1 more source

